192 related articles for article (PubMed ID: 8790406)
1. FHIT gene alterations in head and neck squamous cell carcinomas.
Virgilio L; Shuster M; Gollin SM; Veronese ML; Ohta M; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9770-5. PubMed ID: 8790406
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL
Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317
[TBL] [Abstract][Full Text] [Related]
3. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
Mao L; Fan YH; Lotan R; Hong WK
Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845
[TBL] [Abstract][Full Text] [Related]
4. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
[TBL] [Abstract][Full Text] [Related]
5. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
[TBL] [Abstract][Full Text] [Related]
6. Fhit expression is absent or reduced in a subset of primary head and neck cancer.
Götte K; Hadaczek P; Coy JF; Wirtz HW; Riedel F; Neubauer J; Hörmann K
Anticancer Res; 2000; 20(2A):1057-60. PubMed ID: 10810397
[TBL] [Abstract][Full Text] [Related]
7. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
8. Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region.
van den Berg A; Draaijers TG; Kok K; Timmer T; Van der Veen AY; Veldhuis PM; de Leij L; Gerhartz CD; Naylor SL; Smith DI; Buys CH
Genes Chromosomes Cancer; 1997 Aug; 19(4):220-7. PubMed ID: 9258656
[TBL] [Abstract][Full Text] [Related]
9. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
10. Low expression of fragile histidine triad gene correlates with high proliferation in head and neck squamous cell carcinoma.
Mineta H; Miura K; Takebayashi S; Misawa K; Ueda Y; Suzuki I; Ito M; Wennerberg J
Oral Oncol; 2003 Jan; 39(1):56-63. PubMed ID: 12457722
[TBL] [Abstract][Full Text] [Related]
11. FHIT gene abnormalities in both benign and malignant thyroid tumours.
Zou M; Shi Y; Farid NR; al-Sedairy ST; Paterson MC
Eur J Cancer; 1999 Mar; 35(3):467-72. PubMed ID: 10448301
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; Ablanedo P; Suárez C; Alvarez V; Coto E
J Clin Pathol; 1998 Jul; 51(7):520-4. PubMed ID: 9797729
[TBL] [Abstract][Full Text] [Related]
14. Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication.
Tai SK; Lee JI; Ang KK; El-Naggar AK; Hassan KA; Liu D; Lee JJ; Ren H; Hong WK; Mao L
Clin Cancer Res; 2004 Aug; 10(16):5554-7. PubMed ID: 15328196
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the FHIT gene in human hepatocellular carcinoma.
Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
[TBL] [Abstract][Full Text] [Related]
16. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
Michael D; Beer DG; Wilke CW; Miller DE; Glover TW
Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498
[TBL] [Abstract][Full Text] [Related]
17. Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancer.
Menin C; Santacatterina M; Zambon A; Montagna M; Parenti A; Ruol A; D'Andrea E
Cancer Genet Cytogenet; 2000 May; 119(1):56-61. PubMed ID: 10812172
[TBL] [Abstract][Full Text] [Related]
18. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B
Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464
[TBL] [Abstract][Full Text] [Related]
19. Structure and expression of the human FHIT gene in normal and tumor cells.
Druck T; Hadaczek P; Fu TB; Ohta M; Siprashvili Z; Baffa R; Negrini M; Kastury K; Veronese ML; Rosen D; Rothstein J; McCue P; Cotticelli MG; Inoue H; Croce CM; Huebner K
Cancer Res; 1997 Feb; 57(3):504-12. PubMed ID: 9012482
[TBL] [Abstract][Full Text] [Related]
20. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix.
Yoshino K; Enomoto T; Nakamura T; Nakashima R; Wada H; Saitoh J; Noda K; Murata Y
Int J Cancer; 1998 Apr; 76(2):176-81. PubMed ID: 9537577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
